Director, Cancer Immunology


We are seeking an individual who is passionate about discovering novel therapeutics that harness the immune system in order to eradicate cancer. You will help guide the scientific direction of research and bring novel breakthrough therapeutics from concept to clinical testing. You will achieve a deep understanding of the biology and cellular machinery of immune cells with an emphasis on the pathways that control immune activation, effector function, and cellular regulation, especially in the context of the tumor microenvironment.



About Amphivena

Amphivena Therapeutics, Inc. is a cancer immunotherapy company based in South San Francisco, CA developing proprietary first-in-class, T-cell redirecting bispecific antibody-based proteins for the treatment of cancer. The company’s lead drug candidate is AMV564, a CD33/CD3-targeted treatment for acute myeloid leukemia (AML).

Amphivena’s mission is to eradicate cancers with a breakthrough therapies that harnesses the patient’s own immune system to destroy tumor cells and their precursors. Our aim is to restore the cellular balance needed for proper blood formation, function and circulation, restoring the flow of life to patients.

error: Content is protected !!